And so, for 18 months, from March 2015 to September 2016, every cardiologist and internal medicine specialist and general practice veterinarian was intentionally misled about the essential parameters which had to be met before prescribing pimobendan
Absolute contraindications
But as evidence propositions they are worlds apart: one is an FDA-approved drug with replicated Phase 3 trials, the other is an unapproved research chemical with two small surrogate-marker studies and discontinued development
Sarcopenia: Preliminary evidence suggests ALCAR may preserve muscle mass and function in the elderly by improving mitochondrial efficiency [5][68]
These symptoms can escalate to life-threatening difficulties for individuals with comorbidities such as type II diabetes, frailty, heart disease and general aging
Taglialatela G, Navarra D, Cruciani R, et al